News

Press Release: Sanofi’s SAR446597 earns fast track designation in the US for geographic atrophy due to age-related macular degeneration
Sanofi’s SAR446597 earns fast track designation in the US for geographic atrophy due to age-related macular degeneration Designation earned for a one-time intravitreal gene therapy designed to inhibit ...
Pharmabiz4d
US FDA grants fast track designation to Sanofi’s SAR446597 to treat geographic atrophy due to age-related macular degeneration
US FDA grants fast track designation to Sanofi’s SAR446597 to treat geographic atrophy due to age-related macular degeneration: Paris Thursday, July 17, 2025, 10:00 Hrs [IST] Th ...
Medical Dialogues5d
Sanofi intravitreal gene therapy wins USFDA fast track designation for geographic atrophy due to age-related macular degeneration
Paris: Sanofi has received fast track designation from the US Food and Drug Administration (FDA) for SAR446597, a one-time ...
Nature4d
Retinal diseases - Latest research and news | Nature
Retinal diseases articles from across Nature Portfolio Retinopathy of prematurity Latest Research and Reviews ...